Sialylation shapes mucus architecture inhibiting bacterial invasion in the colon.


Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 13 12 2022
revised: 07 06 2023
accepted: 07 06 2023
pubmed: 30 6 2023
medline: 30 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

In the intestine, mucin 2 (Muc2) forms a network structure and prevents bacterial invasion. Glycans are indispensable for Muc2 barrier function. Among various glycosylation patterns of Muc2, sialylation inhibits bacteria-dependent Muc2 degradation. However, the mechanisms by which Muc2 creates the network structure and sialylation prevents mucin degradation remain unknown. Here, by focusing on two glycosyltransferases, St6 N-acetylgalactosaminide α-2,6-sialyltransferase 6 (St6galnac6) and β-1,3-galactosyltransferase 5 (B3galt5), mediating the generation of desialylated glycans, we show that sialylation forms the network structure of Muc2 by providing negative charge and hydrophilicity. The colonic mucus of mice lacking St6galnac6 and B3galt5 was less sialylated, thinner, and more permeable to microbiota, resulting in high susceptibility to intestinal inflammation. Mice with a B3galt5 mutation associated with inflammatory bowel disease (IBD) also showed the loss of desialylated glycans of mucus and the high susceptibility to intestinal inflammation, suggesting that the reduced sialylation of Muc2 is associated with the pathogenesis of IBD. In mucins of mice with reduced sialylation, negative charge was reduced, the network structure was disturbed, and many bacteria invaded. Thus, sialylation mediates the negative charging of Muc2 and facilitates the formation of the mucin network structure, thereby inhibiting bacterial invasion in the colon to maintain gut homeostasis.

Identifiants

pubmed: 37385587
pii: S1933-0219(23)00049-1
doi: 10.1016/j.mucimm.2023.06.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

624-641

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Mugen Taniguchi (M)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; Infectious Diseases Unit, Department of Medical Innovations, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.

Ryu Okumura (R)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Institute for Open and Transdisciplinary Research Initiative, Osaka University, Osaka, Japan.

Takahisa Matsuzaki (T)

Center for Future Innovation, Graduate School of Engineering, Osaka University, Osaka, Japan; Department of Applied Physics, Graduate School of Engineering, Osaka University, Osaka, Japan.

Ayaka Nakatani (A)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Kei Sakaki (K)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.

Shota Okamoto (S)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Airi Ishibashi (A)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Haruka Tani (H)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Momoka Horikiri (M)

Department of Applied Physics, Graduate School of Engineering, Osaka University, Osaka, Japan.

Naritaka Kobayashi (N)

Department of Electronic Systems Engineering, The University of Shiga Prefecture, Shiga, Japan.

Hiroshi Y Yoshikawa (HY)

Department of Applied Physics, Graduate School of Engineering, Osaka University, Osaka, Japan.

Daisuke Motooka (D)

Institute for Open and Transdisciplinary Research Initiative, Osaka University, Osaka, Japan; Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Daisuke Okuzaki (D)

WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Shota Nakamura (S)

Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Toshiyuki Kida (T)

Institute for Open and Transdisciplinary Research Initiative, Osaka University, Osaka, Japan; Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Osaka, Japan.

Akihiko Kameyama (A)

Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan.

Kiyoshi Takeda (K)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan; Institute for Open and Transdisciplinary Research Initiative, Osaka University, Osaka, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan. Electronic address: ktakeda@ongene.med.osaka-u.ac.jp.

Classifications MeSH